Personalized pharmacotherapy for Type 2 diabetes mellitus

Author： Sathananthan Airani   Vella Adrian  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.6, Iss.4, 2009-07, pp. : 417-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Type 2 diabetes mellitus and bone

By  

JOURNAL OF INTERNAL MEDICINE, Vol. 283, Iss. 2, 2018-02 ,pp. : 140-153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness and safety of glimepiride and iDPP4, associated with metformin in second line pharmacotherapy of type 2 diabetes mellitus: systematic review and meta‐analysis

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 3, 2015-03 ,pp. : 292-304

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bone structure and turnover in type 2 diabetes mellitus

By Shu A.  

Osteoporosis International, Vol. 23, Iss. 2, 2012-02 ,pp. : 635-641

Springer Publishing Company

Access to resources Recommend Favorite

Atrial electromechanical delay in type 2 diabetes mellitus

By Akyel Ahmet   Öksüz Fatih   Karadeniz Muhammed   Yarlıoğlueş Mikail   Ergün Gökhan   Cankurt Tayyar   Yozgat Ahmet   Keskin Arıel Müge   Aral Yalçın   Murat Sani Namık  

Wiener klinische Wochenschrift, Vol. 126, Iss. 3-4, 2014-02 ,pp. : 101-105

Springer Publishing Company

Access to resources Recommend Favorite

Treatment intensification in type 2 diabetes mellitus and obesity

By Zawiejska Agnieszka   McAleese Jane   Yemparala Prasad   Taheri Shahrad  

British Journal of General Practice, Vol. 63, Iss. 609, 2013-04 ,pp. : 182-182

Royal College of General Practitioners

Access to resources Recommend Favorite